Menu
Washingtoner
  • Home
  • Business
  • Aerospace
  • Transportation
  • Boeing
  • Construction
  • ANSI-ANAB
  • Crypto
  • Kelly Ortberg
Washingtoner

FreezeNit Announces Exclusive Licensing of Novel Non-Toxic Lice Treatment Technology
Washingtoner/10287890

Trending...
  • 2026 Oscars Betting Odds: One Battle After Another Favored for Best Picture
  • Emeritus Addresses Hospital Bed Shortages with Smart Storage Solutions
  • Spokane: Firework Thrown From a Vehicle Causes Severe Injuries to Another
FreezeNit
Naturally-Derived OTC Gel Eliminates Lice Without Neurotoxins, Launching Spring 2025

MARBLEHEAD, Mass. - Washingtoner -- FreezeNit, a leader in innovative lice treatment solutions, is thrilled to announce the exclusive licensing of a novel over-the-counter (OTC) lice treatment gel designed to provide a safe, naturally-derived, and highly effective alternative to traditional synthetic or pesticide-based lice treatments.

Unlike conventional OTC lice treatments that rely on pesticide-based pyrethroids, which have decreasing efficacy due to lice resistance, this new technology works by a purely mechanical method of action to eliminate lice and their eggs. The patented formula is free from harsh chemicals and instead leverages natural abrasives, such as diatomaceous earth and walnut shell powder, orange oil extract, and conditioning agents to physically shred lice and nits, while being gentle on the hair and scalp.

This addition strengthens FreezeNit's growing product portfolio, reinforcing the company's mission to provide clean, effective, science-backed treatments that parents can trust.

"This is an incredibly exciting milestone for FreezeNit," said Joanna Shu, CEO of FreezeNit. "By securing exclusive rights to this novel technology, we're positioned to be on the cutting edge of first aid treatments that are gentle on kids. Traditional lice treatments have failed parents and kids, but with this gel, lice don't stand a chance."

More on Washingtoner
  • The Kryder Law Group, LLC Report Reveals Commercial Air Travel Is Safer Than You Think
  • RTC Communications Preliminarily Awarded $3.1 Million Federal BEAD Grant to Expand Fiber Broadband in Southern Indiana
  • She's Been Ready for Weeks, He Starts in the Final 72 Hours – The Great Christmas Shopping Divide
  • Following a Global Sell-Out, The World's No.1 Superstar™ Unveils a Fashion Line Rebrand
  • Valentine Roofing Wins 2025 Nextdoor Neighborhood Fave Award

✔ Clinically Proven – was shown to be 96% effective in a clinical trial.
✔ No Resistance Issues – Unlike permethrin-based treatments, which have seen increased lice resistance, this technology works mechanically—not chemically—so lice cannot develop immunity.
✔ Patented & Protected – This novel formula and method of action is patented in the U.S., Canada, and the EU, ensuring exclusivity in the market.
✔ Class I, 510(k) Exempt – The FDA-regulated status allows for a fast-tracked market entry.

FreezeNit is actively engaging with retailers, distributors, and healthcare providers to bring this breakthrough lice treatment to families everywhere.

FreezeNit is an innovative healthcare company dedicated to revolutionizing first-aid with safe, effective, and science-backed solutions. By leveraging cutting-edge technology and natural alternatives to neurotoxins, FreezeNit provides families with fast, reliable, and pesticide-free treatments for head lice infestations.  For more information, visit www.FreezeNit.com.

Media Contact
Cathy Henry
cathy@freezenit.com
214-924-5992


Source: FreezeNit

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on Washingtoner
  • Tacoma: Update on Initiative 2
  • ReedSmith® Celebrates Innovative Founders at TCVN's Survivor™ XII at SoCal Startup Day
  • The global race for next-gen precious metals recovery is accelerating: $AABB is positioning itself with it's Revolutionary rGO Gold Recovery System
  • NorthSky Celebrates One-Year Anniversary
  • Free At Last Bail Bonds Gives Back Through Major Holiday Food Distribution Efforts Across Metro Atlanta
  • Discover Elevated Living - Preview the Stunning New Townhome Collection
  • TownePlace Suites Prescott Valley, AZ Opens
  • SIX7 Introduces Olfactory Neurodesign™ — The First Fragrance System Engineered to Influence Emotion, Memory, and Desire at the Neural Level
  • GetKuwa emerging as GCC's #1 trusted online supplement marketplace as shoppers across UAE, Saudi Arabia, Kuwait, Qatar & Oman seek authenticity
  • GenesisEdge Society Unveils ΣClipse AI Multi-Agent System Led by Richard Schmidt
  • Uk Financial Ltd Provides Investors Of Maya Preferred & Mayacat Instructions For Upcoming First Ever Listing Of Both Erc-3643 "SEC-Ready" Tokens
  • Tacoma Creates 2024-2025 Annual Report Highlights Expanded Access to Arts and Culture Across Tacoma
  • Kaufman Development and Daniel Kaufman Ventures Announce Strategic Expansion Into Data Centers and AI Infrastructure Across the United States
  • Tacoma: City Council Presented with Community Safety Action Strategy Built on Community Input
  • City Council Presented With 'Tacoma 2035'
  • Bent Danholm Lists Modern Lakefront Estate in Winter Garden's Twinwaters Community
  • Operational Agility in High Demand: FOCUS Expands to Serve a Changing Insurance Market
  • Bahamas Import Assistant Launches Same-Day Pet Permit Service Under BAHFSA's 2024 Expansion
  • Liftoff Enterprises Launches Liftoff Spotlight,™ A Nationally Broadcast Platform Turning Conversations Into Revenue
  • From November 24th to 27th, Fuqing Invites You to Join Us at BIG 5 to Jointly Build a New Future for Middle Eastern Architecture
_catLbl0 _catLbl1

Popular on Washingtoner

  • New Article by Roy J. Meidinger – Examines Hidden Hidden Healthcare Kickbacks - 141
  • Applicants Sought for the Tacoma Community Redevelopment Authority Board
  • ExtraCarry Now Supports Taurus GX2 13-Round Mags and 15-Round Magazines
  • Oom Yung Doe Hosts Children's Halloween Safety Seminar in Kirkland
  • Award-Winning Author Zane Carson Carruth Featured in USA Today for Inspiring Mission to Nurture Young Hearts Through Storytelling
  • Frost Locker: New Research Reveals Mild Cold—Not Extreme Cold—Delivers Real Health Benefits of Cold Therapy
  • City of Tacoma’s Street Operations Crew Scheduled to Conduct Annual Snow and Ice Training on October 22 and 23
  • Blogging Pioneer Sherry Bennett Celebrates 29 Years Online - From College Blogger to Successful Entrepreneur
  • Pepperdine University Malibu, California and Community Partners Recognized with 2025 ReadyCommunities Partnership National Service Award
  • Parkchester Oral & Maxillofacial Surgery Celebrates 450+ 5-Star Reviews

Similar on Washingtoner

  • BumblebeeSmart Introduces Rounded Busy Board Set for Preschoolers
  • CRH Healthcare Opens 100th Urgent Care Clinic with Second Peachtree Immediate Care Location in Covington
  • She's Been Ready for Weeks, He Starts in the Final 72 Hours – The Great Christmas Shopping Divide
  • Following a Global Sell-Out, The World's No.1 Superstar™ Unveils a Fashion Line Rebrand
  • Metro Detroit teen Lola Winters turns viral TikTok fame into a sold-out clothing brand
  • NorthSky Celebrates One-Year Anniversary
  • SIX7 Introduces Olfactory Neurodesign™ — The First Fragrance System Engineered to Influence Emotion, Memory, and Desire at the Neural Level
  • GetKuwa emerging as GCC's #1 trusted online supplement marketplace as shoppers across UAE, Saudi Arabia, Kuwait, Qatar & Oman seek authenticity
  • Bahamas Import Assistant Launches Same-Day Pet Permit Service Under BAHFSA's 2024 Expansion
  • Dispelling Holiday Suicide Myth: CDC Data Shows Suicide Rates Lowest in December; International Survivors of Suicide Day Emphasizes Need for Action
Copyright © 2025 washingtoner.com | Terms of Service | Privacy Policy | Contact Us | Contribute